Late‐Stage C−H Activation of Drug (Derivative) Molecules with Pd(ll) Catalysis

• Published in: Chemistry : a European journal 2023-12, Vol.29 (71), p.e202302620-n/a
• Main Author: Shim, Su Yong
• Format: Article
• Language: English
• Subjects: Alkynes; Aromatic compounds; Catalysis; Catalysts; Chemistry; Chlorine; C−H activation; drug; Drug development; Fluorine; Functional groups; Hydroxyl groups; late-stage C−H activation; late-stage functionalization; Medical innovations; Palladium; Pd catalyst; Regioselectivity
• ISSN: 0947-6539; 1521-3765
• DOI: 10.1002/chem.202302620

This review comprehensively analyses representative examples of Pd(II)‐catalyzed late‐stage C−H activation reactions and demonstrates their efficacy in converting C−H bonds at multiple positions within drug (derivative) molecules into diverse functional groups. These transformative reactions hold immense potential in medicinal chemistry, enabling the efficient and selective functionalization of specific sites within drug molecules, thereby enhancing their pharmacological activity and expanding the scope of potential drug candidates. Although notable articles have focused on late‐stage C−H functionalization reactions of drug‐like molecules using transition‐metal catalysts, reviews specifically focusing on late‐stage C−H functionalization reactions of drug (derivative) molecules using Pd(II) catalysts are required owing to their prominence as the most widely utilized metal catalysts for C−H activation and their ability to introduce a myriad of functional groups at specific C−H bonds. The utilization of Pd‐catalyzed C−H activation methodologies demonstrates impressive success in introducing various functional groups, such as cyano (CN), fluorine (F), chlorine (Cl), aromatic rings, olefin, alkyl, alkyne, and hydroxyl groups, to drug (derivative) molecules with high regioselectivity and functional‐group tolerance. These breakthroughs in late‐stage C−H activation reactions serve as invaluable tools for drug discovery and development, thereby offering strategic options to optimize drug candidates and drive the exploration of innovative therapeutic solutions. This review emphasizes and comprehensively analyses representative examples of palladium(II)‐catalyzed late‐stage C−H activation reactions and demonstrates their efficacy in converting C−H bonds at multiple positions within drug (derivative) molecules into diverse functional groups. Specifically, this study elucidates the notable strides made in the realm of late‐stage C−H activation of drug (derivatives) molecules employing Pd (II) catalysts.